25 XP   0   0   10

Shanghai RAAS Blood Products Co Ltd Class A
Buy, Hold or Sell?

Let's analyse Shanghai RAAS Blood Products Co Ltd Class A together

PenkeI guess you are interested in Shanghai RAAS Blood Products Co Ltd Class A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai RAAS Blood Products Co Ltd Class A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shanghai RAAS Blood Products Co Ltd Class A

I send you an email if I find something interesting about Shanghai RAAS Blood Products Co Ltd Class A.

Quick analysis of Shanghai RAAS Blood Products Co Ltd Class A (30 sec.)










What can you expect buying and holding a share of Shanghai RAAS Blood Products Co Ltd Class A? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.27
Expected worth in 1 year
¥6.00
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥1.84
Return On Investment
25.3%

For what price can you sell your share?

Current Price per Share
¥7.26
Expected price per share
¥6.064 - ¥8.6
How sure are you?
50%

1. Valuation of Shanghai RAAS Blood Products Co Ltd Class A (5 min.)




Live pricePrice per Share (EOD)

¥7.26

Intrinsic Value Per Share

¥1.62 - ¥3.33

Total Value Per Share

¥5.90 - ¥7.60

2. Growth of Shanghai RAAS Blood Products Co Ltd Class A (5 min.)




Is Shanghai RAAS Blood Products Co Ltd Class A growing?

Current yearPrevious yearGrowGrow %
How rich?$3.9b$3.5b$401.4m10.1%

How much money is Shanghai RAAS Blood Products Co Ltd Class A making?

Current yearPrevious yearGrowGrow %
Making money$259.4m$178.6m$80.8m31.1%
Net Profit Margin28.6%30.2%--

How much money comes from the company's main activities?

3. Financial Health of Shanghai RAAS Blood Products Co Ltd Class A (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#20 / 1010

Most Revenue
#22 / 1010

Most Profit
#16 / 1010

Most Efficient
#56 / 1010

What can you expect buying and holding a share of Shanghai RAAS Blood Products Co Ltd Class A? (5 min.)

Welcome investor! Shanghai RAAS Blood Products Co Ltd Class A's management wants to use your money to grow the business. In return you get a share of Shanghai RAAS Blood Products Co Ltd Class A.

What can you expect buying and holding a share of Shanghai RAAS Blood Products Co Ltd Class A?

First you should know what it really means to hold a share of Shanghai RAAS Blood Products Co Ltd Class A. And how you can make/lose money.

Speculation

The Price per Share of Shanghai RAAS Blood Products Co Ltd Class A is ¥7.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai RAAS Blood Products Co Ltd Class A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai RAAS Blood Products Co Ltd Class A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.27. Based on the TTM, the Book Value Change Per Share is ¥0.43 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai RAAS Blood Products Co Ltd Class A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.5%0.040.5%0.030.4%0.010.2%0.020.2%
Usd Book Value Change Per Share0.060.8%0.060.8%0.020.2%0.070.9%0.060.8%
Usd Dividend Per Share0.000.1%0.000.1%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.060.9%0.060.9%0.020.3%0.070.9%0.060.8%
Usd Price Per Share0.87-0.87-0.94-0.99-2.92-
Price to Earnings Ratio22.73-22.73-35.51-28.40-336.02-
Price-to-Total Gains Ratio13.80-13.80-48.77-22.18-349.03-
Price to Book Ratio1.48-1.48-1.77-2.88-38.40-
Price-to-Total Gains Ratio13.80-13.80-48.77-22.18-349.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.00188
Number of shares998
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.060.07
Usd Total Gains Per Share0.060.07
Gains per Quarter (998 shares)63.2968.44
Gains per Year (998 shares)253.18273.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11523824310264264
23147649619528538
34671374929792812
46295110023910561086
577118912554913201360
693142715085815841634
7108166417616818481908
8123190220147821122182
9139214022678823762456
10154237825209726402730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%17.01.00.094.4%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%16.02.00.088.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%16.02.00.088.9%

Fundamentals of Shanghai RAAS Blood Products Co Ltd Class A

About Shanghai RAAS Blood Products Co Ltd Class A

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.

Fundamental data was last updated by Penke on 2024-04-14 14:20:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Shanghai RAAS Blood Products Co Ltd Class A.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shanghai RAAS Blood Products Co Ltd Class A earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai RAAS Blood Products Co Ltd Class A to the Biotechnology industry mean.
  • A Net Profit Margin of 28.6% means that ¥0.29 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 28.6%. The company is making a huge profit. +2
  • The TTM is 28.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.6%TTM28.6%0.0%
TTM28.6%YOY30.2%-1.6%
TTM28.6%5Y9.2%+19.4%
5Y9.2%10Y29.8%-20.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.6%-207.2%+235.8%
TTM28.6%-216.8%+245.4%
YOY30.2%-282.3%+312.5%
5Y9.2%-436.8%+446.0%
10Y29.8%-597.3%+627.1%
1.1.2. Return on Assets

Shows how efficient Shanghai RAAS Blood Products Co Ltd Class A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai RAAS Blood Products Co Ltd Class A to the Biotechnology industry mean.
  • 6.2% Return on Assets means that Shanghai RAAS Blood Products Co Ltd Class A generated ¥0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 6.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.2%TTM6.2%0.0%
TTM6.2%YOY4.8%+1.4%
TTM6.2%5Y1.6%+4.6%
5Y1.6%10Y5.3%-3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2%-13.3%+19.5%
TTM6.2%-12.8%+19.0%
YOY4.8%-11.6%+16.4%
5Y1.6%-13.8%+15.4%
10Y5.3%-15.6%+20.9%
1.1.3. Return on Equity

Shows how efficient Shanghai RAAS Blood Products Co Ltd Class A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai RAAS Blood Products Co Ltd Class A to the Biotechnology industry mean.
  • 6.5% Return on Equity means Shanghai RAAS Blood Products Co Ltd Class A generated ¥0.07 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 6.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.5%TTM6.5%0.0%
TTM6.5%YOY5.0%+1.5%
TTM6.5%5Y1.6%+4.9%
5Y1.6%10Y6.1%-4.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5%-16.9%+23.4%
TTM6.5%-16.1%+22.6%
YOY5.0%-14.9%+19.9%
5Y1.6%-19.3%+20.9%
10Y6.1%-20.1%+26.2%

1.2. Operating Efficiency of Shanghai RAAS Blood Products Co Ltd Class A.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shanghai RAAS Blood Products Co Ltd Class A is operating .

  • Measures how much profit Shanghai RAAS Blood Products Co Ltd Class A makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai RAAS Blood Products Co Ltd Class A to the Biotechnology industry mean.
  • An Operating Margin of 30.9% means the company generated ¥0.31  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 30.9%. The company is operating very efficient. +2
  • The TTM is 30.9%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.9%TTM30.9%0.0%
TTM30.9%YOY34.6%-3.7%
TTM30.9%5Y32.2%-1.3%
5Y32.2%10Y29.1%+3.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ30.9%-298.0%+328.9%
TTM30.9%-238.5%+269.4%
YOY34.6%-288.4%+323.0%
5Y32.2%-486.2%+518.4%
10Y29.1%-628.4%+657.5%
1.2.2. Operating Ratio

Measures how efficient Shanghai RAAS Blood Products Co Ltd Class A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.25 means that the operating costs are ¥1.25 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 1.248. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.248. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.248TTM1.2480.000
TTM1.248YOY1.133+0.115
TTM1.2485Y1.077+0.171
5Y1.07710Y0.818+0.259
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2483.235-1.987
TTM1.2483.310-2.062
YOY1.1333.838-2.705
5Y1.0775.679-4.602
10Y0.8187.823-7.005

1.3. Liquidity of Shanghai RAAS Blood Products Co Ltd Class A.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shanghai RAAS Blood Products Co Ltd Class A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.22 means the company has ¥5.22 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 5.215. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.215. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.215TTM5.2150.000
TTM5.215YOY5.260-0.044
TTM5.2155Y9.902-4.687
5Y9.90210Y6.693+3.209
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2153.863+1.352
TTM5.2154.169+1.046
YOY5.2605.337-0.077
5Y9.9026.122+3.780
10Y6.6936.434+0.259
1.3.2. Quick Ratio

Measures if Shanghai RAAS Blood Products Co Ltd Class A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai RAAS Blood Products Co Ltd Class A to the Biotechnology industry mean.
  • A Quick Ratio of 0.58 means the company can pay off ¥0.58 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 0.582. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.582. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.582TTM0.5820.000
TTM0.582YOY0.526+0.056
TTM0.5825Y2.015-1.434
5Y2.01510Y3.233-1.217
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5823.504-2.922
TTM0.5823.991-3.409
YOY0.5265.371-4.845
5Y2.0156.088-4.073
10Y3.2336.395-3.162

1.4. Solvency of Shanghai RAAS Blood Products Co Ltd Class A.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shanghai RAAS Blood Products Co Ltd Class A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai RAAS Blood Products Co Ltd Class A to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Shanghai RAAS Blood Products Co Ltd Class A assets are financed with 5.4% credit (debt) and the remaining percentage (100% - 5.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 0.054. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.054. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.054TTM0.0540.000
TTM0.054YOY0.049+0.005
TTM0.0545Y0.038+0.016
5Y0.03810Y0.089-0.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0540.339-0.285
TTM0.0540.337-0.283
YOY0.0490.271-0.222
5Y0.0380.368-0.330
10Y0.0890.388-0.299
1.4.2. Debt to Equity Ratio

Measures if Shanghai RAAS Blood Products Co Ltd Class A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai RAAS Blood Products Co Ltd Class A to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.7% means that company has ¥0.06 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The MRQ is 0.057. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.057. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.057TTM0.0570.000
TTM0.057YOY0.051+0.006
TTM0.0575Y0.040+0.017
5Y0.04010Y0.109-0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0570.392-0.335
TTM0.0570.403-0.346
YOY0.0510.335-0.284
5Y0.0400.427-0.387
10Y0.1090.461-0.352

2. Market Valuation of Shanghai RAAS Blood Products Co Ltd Class A

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai RAAS Blood Products Co Ltd Class A generates.

  • Above 15 is considered overpriced but always compare Shanghai RAAS Blood Products Co Ltd Class A to the Biotechnology industry mean.
  • A PE ratio of 22.73 means the investor is paying ¥22.73 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The EOD is 26.030. Based on the earnings, the company is overpriced. -1
  • The MRQ is 22.731. Based on the earnings, the company is fair priced.
  • The TTM is 22.731. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD26.030MRQ22.731+3.299
MRQ22.731TTM22.7310.000
TTM22.731YOY35.513-12.782
TTM22.7315Y28.397-5.666
5Y28.39710Y336.018-307.620
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD26.030-2.300+28.330
MRQ22.731-2.656+25.387
TTM22.731-2.718+25.449
YOY35.513-4.145+39.658
5Y28.397-6.258+34.655
10Y336.018-6.315+342.333
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The EOD is 32.628. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 28.494. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 28.494. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD32.628MRQ28.494+4.135
MRQ28.494TTM28.4940.000
TTM28.494YOY42.199-13.706
TTM28.4945Y139.607-111.113
5Y139.60710Y341.842-202.235
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD32.628-2.974+35.602
MRQ28.494-3.306+31.800
TTM28.494-3.508+32.002
YOY42.199-5.613+47.812
5Y139.607-8.378+147.985
10Y341.842-8.873+350.715
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shanghai RAAS Blood Products Co Ltd Class A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.48 means the investor is paying ¥1.48 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Shanghai RAAS Blood Products Co Ltd Class A:

  • The EOD is 1.698. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.483. Based on the equity, the company is underpriced. +1
  • The TTM is 1.483. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.698MRQ1.483+0.215
MRQ1.483TTM1.4830.000
TTM1.483YOY1.775-0.291
TTM1.4835Y2.884-1.401
5Y2.88410Y38.400-35.516
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6981.914-0.216
MRQ1.4832.116-0.633
TTM1.4832.097-0.614
YOY1.7752.881-1.106
5Y2.8843.550-0.666
10Y38.4003.936+34.464
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shanghai RAAS Blood Products Co Ltd Class A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4320.4320%0.115+276%0.479-10%0.412+5%
Book Value Per Share--4.2744.2740%3.843+11%3.043+40%2.193+95%
Current Ratio--5.2155.2150%5.260-1%9.902-47%6.693-22%
Debt To Asset Ratio--0.0540.0540%0.049+10%0.038+41%0.089-40%
Debt To Equity Ratio--0.0570.0570%0.051+11%0.040+43%0.109-48%
Dividend Per Share--0.0280.0280%0.025+12%0.018+58%0.018+53%
Eps--0.2790.2790%0.192+45%0.106+163%0.121+130%
Free Cash Flow Per Share--0.2230.2230%0.162+38%0.129+73%0.099+126%
Free Cash Flow To Equity Per Share--0.1940.1940%0.135+44%0.067+188%0.092+110%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.330--------
Intrinsic Value_10Y_min--1.621--------
Intrinsic Value_1Y_max--0.208--------
Intrinsic Value_1Y_min--0.116--------
Intrinsic Value_3Y_max--0.722--------
Intrinsic Value_3Y_min--0.391--------
Intrinsic Value_5Y_max--1.350--------
Intrinsic Value_5Y_min--0.710--------
Market Cap48246184335.360+11%42736595330.38042736595330.3800%45972173525.740-7%48226070956.080-11%140621523261.193-70%
Net Profit Margin--0.2860.2860%0.302-5%0.092+210%0.298-4%
Operating Margin--0.3090.3090%0.346-11%0.322-4%0.291+6%
Operating Ratio--1.2481.2480%1.133+10%1.077+16%0.818+53%
Pb Ratio1.698+13%1.4831.4830%1.775-16%2.884-49%38.400-96%
Pe Ratio26.030+13%22.73122.7310%35.513-36%28.397-20%336.018-93%
Price Per Share7.260+13%6.3406.3400%6.820-7%7.198-12%21.131-70%
Price To Free Cash Flow Ratio32.628+13%28.49428.4940%42.199-32%139.607-80%341.842-92%
Price To Total Gains Ratio15.797+13%13.79513.7950%48.769-72%22.182-38%349.033-96%
Quick Ratio--0.5820.5820%0.526+11%2.015-71%3.233-82%
Return On Assets--0.0620.0620%0.048+30%0.016+290%0.053+17%
Return On Equity--0.0650.0650%0.050+31%0.016+301%0.061+6%
Total Gains Per Share--0.4600.4600%0.140+229%0.497-8%0.430+7%
Usd Book Value--3976241110.6513976241110.6510%3574774998.023+11%2821571111.779+41%2026940513.955+96%
Usd Book Value Change Per Share--0.0600.0600%0.016+276%0.066-10%0.057+5%
Usd Book Value Per Share--0.5900.5900%0.530+11%0.420+40%0.303+95%
Usd Dividend Per Share--0.0040.0040%0.003+12%0.002+58%0.003+53%
Usd Eps--0.0380.0380%0.027+45%0.015+163%0.017+130%
Usd Free Cash Flow--206981653.830206981653.8300%150337913.655+38%119501847.073+73%82048678.322+152%
Usd Free Cash Flow Per Share--0.0310.0310%0.022+38%0.018+73%0.014+126%
Usd Free Cash Flow To Equity Per Share--0.0270.0270%0.019+44%0.009+188%0.013+110%
Usd Market Cap6657973438.280+11%5897650155.5925897650155.5920%6344159946.552-7%6655197791.939-11%19405770210.045-70%
Usd Price Per Share1.002+13%0.8750.8750%0.941-7%0.993-12%2.916-70%
Usd Profit--259452429.232259452429.2320%178642386.963+45%99023497.000+162%112247186.301+131%
Usd Revenue--906273404.184906273404.1840%591706291.454+53%496960818.283+82%359966065.821+152%
Usd Total Gains Per Share--0.0630.0630%0.019+229%0.069-8%0.059+7%
 EOD+4 -4MRQTTM+0 -0YOY+25 -105Y+21 -1410Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of Shanghai RAAS Blood Products Co Ltd Class A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1526.030
Price to Book Ratio (EOD)Between0-11.698
Net Profit Margin (MRQ)Greater than00.286
Operating Margin (MRQ)Greater than00.309
Quick Ratio (MRQ)Greater than10.582
Current Ratio (MRQ)Greater than15.215
Debt to Asset Ratio (MRQ)Less than10.054
Debt to Equity Ratio (MRQ)Less than10.057
Return on Equity (MRQ)Greater than0.150.065
Return on Assets (MRQ)Greater than0.050.062
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Shanghai RAAS Blood Products Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.428
Ma 20Greater thanMa 506.967
Ma 50Greater thanMa 1007.083
Ma 100Greater thanMa 2007.314
OpenGreater thanClose7.080
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets30,457,959
Total Liabilities1,644,618
Total Stockholder Equity28,818,712
 As reported
Total Liabilities 1,644,618
Total Stockholder Equity+ 28,818,712
Total Assets = 30,457,959

Assets

Total Assets30,457,959
Total Current Assets8,473,410
Long-term Assets21,984,550
Total Current Assets
Cash And Cash Equivalents 3,977,425
Short-term Investments 237,767
Net Receivables 707,021
Inventory 3,268,843
Other Current Assets 67,123
Total Current Assets  (as reported)8,473,410
Total Current Assets  (calculated)8,258,180
+/- 215,230
Long-term Assets
Property Plant Equipment 1,281,575
Goodwill 4,702,869
Intangible Assets 175,487
Other Assets 891,193
Long-term Assets  (as reported)21,984,550
Long-term Assets  (calculated)7,051,124
+/- 14,933,426

Liabilities & Shareholders' Equity

Total Current Liabilities1,624,664
Long-term Liabilities19,955
Total Stockholder Equity28,818,712
Total Current Liabilities
Accounts payable 1,137,691
Other Current Liabilities 362,556
Total Current Liabilities  (as reported)1,624,664
Total Current Liabilities  (calculated)1,500,247
+/- 124,416
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,846
Other Liabilities 18,108
Long-term Liabilities  (as reported)19,955
Long-term Liabilities  (calculated)19,955
+/- 0
Total Stockholder Equity
Common Stock6,740,788
Retained Earnings 7,533,195
Total Stockholder Equity (as reported)28,818,712
Total Stockholder Equity (calculated)14,273,983
+/- 14,544,729
Other
Capital Stock6,740,788
Common Stock Shares Outstanding 6,740,788
Net Invested Capital 28,818,712
Net Tangible Assets 23,940,357
Net Working Capital 6,848,746
Property Plant and Equipment Gross 1,281,575



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
333,635
325,164
306,538
831,190
825,217
930,326
1,009,530
1,208,261
1,575,147
9,379,459
11,556,012
13,225,627
14,455,420
11,387,345
11,853,051
25,493,799
27,236,582
30,457,959
30,457,95927,236,58225,493,79911,853,05111,387,34514,455,42013,225,62711,556,0129,379,4591,575,1471,208,2611,009,530930,326825,217831,190306,538325,164333,635
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
6,072,661
6,938,611
3,912,441
4,530,962
5,012,129
6,872,251
8,473,410
8,473,4106,872,2515,012,1294,530,9623,912,4416,938,6116,072,66100000000000
       Cash And Cash Equivalents 
22,562
23,627
56,393
557,878
463,400
457,827
363,119
362,101
329,544
1,450,465
1,918,826
2,085,890
1,385,834
864,022
1,436,417
1,951,213
2,745,585
3,977,425
3,977,4252,745,5851,951,2131,436,417864,0221,385,8342,085,8901,918,8261,450,465329,544362,101363,119457,827463,400557,87856,39323,62722,562
       Short-term Investments 
0
0
0
0
0
0
0
0
0
2,000
1,613,124
2,157,065
3,136,361
327,050
295,400
262,143
219,385
237,767
237,767219,385262,143295,400327,0503,136,3612,157,0651,613,1242,000000000000
       Net Receivables 
125,619
115,306
49,488
21,207
37,418
28,211
79,353
93,861
134,708
488,677
546,662
1,009,599
1,232,240
1,029,008
867,824
403,391
467,916
707,021
707,021467,916403,391867,8241,029,0081,232,2401,009,599546,662488,677134,70893,86179,35328,21137,41821,20749,488115,306125,619
       Other Current Assets 
12,628
7,674
16,898
17,049
11,378
7,676
10,801
9,767
141,918
30,810
12,769
17,122
19,187
8,590
17,810
50,580
78,300
67,123
67,12378,30050,58017,8108,59019,18717,12212,76930,810141,9189,76710,8017,67611,37817,04916,8987,67412,628
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
7,152,965
7,516,809
7,474,904
7,322,089
20,481,669
20,364,331
21,984,550
21,984,55020,364,33120,481,6697,322,0897,474,9047,516,8097,152,96500000000000
       Property Plant Equipment 
85,064
91,779
102,017
110,386
154,890
251,336
391,218
550,935
618,430
1,055,528
1,067,525
1,171,889
1,116,577
1,126,103
1,164,490
1,228,820
1,278,586
1,281,575
1,281,5751,278,5861,228,8201,164,4901,126,1031,116,5771,171,8891,067,5251,055,528618,430550,935391,218251,336154,890110,386102,01791,77985,064
       Goodwill 
0
0
0
0
0
0
0
0
0
5,420,121
5,420,121
5,640,638
5,704,977
5,518,590
5,390,765
5,261,085
4,899,892
4,702,869
4,702,8694,899,8925,261,0855,390,7655,518,5905,704,9775,640,6385,420,1215,420,121000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
5,583,068
5,582,474
236,615
207,037
195,271
183,795
172,417
163,177
175,487
175,487163,177172,417183,795195,271207,037236,6155,582,4745,583,068000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
65,460
23,537
20,569
17,042
392,704
598,293
775,825
775,825598,293392,70417,04220,56923,53765,46000000000000
> Total Liabilities 
101,935
168,392
136,528
76,425
61,884
99,116
82,257
188,787
473,369
755,161
843,641
1,495,309
1,975,274
495,180
361,951
363,735
1,332,415
1,644,618
1,644,6181,332,415363,735361,951495,1801,975,2741,495,309843,641755,161473,369188,78782,25799,11661,88476,425136,528168,392101,935
   > Total Current Liabilities 
101,935
168,392
136,528
76,425
51,884
87,616
69,347
161,437
90,150
273,121
246,990
871,316
663,863
424,601
309,402
330,238
1,306,626
1,624,664
1,624,6641,306,626330,238309,402424,601663,863871,316246,990273,12190,150161,43769,34787,61651,88476,425136,528168,392101,935
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
24,000
0
150,000
0
0
0
0
0000150,000024,00000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
24,000
0
150,000
0
7,741
0
0
007,7410150,000024,00000000000000
       Accounts payable 
18,713
9,059
7,654
6,710
6,539
22,606
21,849
50,652
53,343
70,870
39,350
48,733
46,782
48,640
52,716
97,113
966,052
1,137,691
1,137,691966,05297,11352,71648,64046,78248,73339,35070,87053,34350,65221,84922,6066,5396,7107,6549,05918,713
       Other Current Liabilities 
25,222
102,333
90,874
40,704
45,345
65,010
47,498
110,785
36,807
202,252
207,640
662,416
106,650
24,255
75,519
41,501
229,358
362,556
362,556229,35841,50175,51924,255106,650662,416207,640202,25236,807110,78547,49865,01045,34540,70490,874102,33325,222
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
623,993
1,311,411
70,578
52,549
33,497
25,790
19,955
19,95525,79033,49752,54970,5781,311,411623,99300000000000
       Other Liabilities 
0
0
0
0
10,000
11,500
12,910
27,350
26,686
110,438
94,043
263,993
1,311,411
70,578
52,549
33,497
21,634
18,108
18,10821,63433,49752,54970,5781,311,411263,99394,043110,43826,68627,35012,91011,50010,0000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
12,696
22,686
19,536
32,162
33,174
28,973
25,775
25,77528,97333,17432,16219,53622,68612,69600000000000
> Total Stockholder Equity
231,450
156,474
168,052
751,234
758,568
824,067
914,642
1,003,656
1,087,235
8,609,713
10,658,472
11,708,763
12,461,759
10,877,579
11,478,696
25,122,780
25,902,446
28,818,712
28,818,71225,902,44625,122,78011,478,69610,877,57912,461,75911,708,76310,658,4728,609,7131,087,2351,003,656914,642824,067758,568751,234168,052156,474231,450
   Common Stock
43,409
43,409
120,000
160,000
160,000
272,000
272,000
489,600
489,600
1,365,242
2,758,753
4,965,756
4,970,239
4,974,622
4,974,622
6,740,788
6,740,788
6,740,788
6,740,7886,740,7886,740,7884,974,6224,974,6224,970,2394,965,7562,758,7531,365,242489,600489,600272,000272,000160,000160,000120,00043,40943,409
   Retained Earnings 
140,164
59,054
35,317
129,598
123,856
171,067
242,200
308,138
412,164
978,417
2,284,307
3,759,523
4,446,245
2,843,279
3,459,020
4,715,323
5,842,998
7,533,195
7,533,1955,842,9984,715,3233,459,0202,843,2794,446,2453,759,5232,284,307978,417412,164308,138242,200171,067123,856129,59835,31759,054140,164
   Capital Surplus 000000000000000000
   Treasury Stock000000-17,196-34,393-3,127000000000
   Other Stockholders Equity -15,718-1,240,845-891,489-14,193-15,9580000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,551,025
Cost of Revenue-4,397,756
Gross Profit3,153,2693,153,269
 
Operating Income (+$)
Gross Profit3,153,269
Operating Expense-5,316,162
Operating Income2,234,864-2,162,892
 
Operating Expense (+$)
Research Development176,073
Selling General Administrative478,409
Selling And Marketing Expenses-
Operating Expense5,316,162654,482
 
Net Interest Income (+$)
Interest Income62,807
Interest Expense-125
Other Finance Cost-75,922
Net Interest Income138,604
 
Pretax Income (+$)
Operating Income2,234,864
Net Interest Income138,604
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,481,7712,234,864
EBIT - interestExpense = -125
2,063,883
2,064,009
Interest Expense125
Earnings Before Interest and Taxes (EBIT)-2,481,896
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax2,481,771
Tax Provision-422,708
Net Income From Continuing Ops2,059,0632,059,063
Net Income2,063,883
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--138,604
 

Technical Analysis of Shanghai RAAS Blood Products Co Ltd Class A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai RAAS Blood Products Co Ltd Class A. The general trend of Shanghai RAAS Blood Products Co Ltd Class A is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai RAAS Blood Products Co Ltd Class A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai RAAS Blood Products Co Ltd Class A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.65 < 7.89 < 8.6.

The bearish price targets are: 6.66 > 6.1338 > 6.064.

Tweet this
Shanghai RAAS Blood Products Co Ltd Class A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai RAAS Blood Products Co Ltd Class A. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai RAAS Blood Products Co Ltd Class A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai RAAS Blood Products Co Ltd Class A. The current macd is -0.00662446.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanghai RAAS Blood Products Co Ltd Class A price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shanghai RAAS Blood Products Co Ltd Class A. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shanghai RAAS Blood Products Co Ltd Class A price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) ChartShanghai RAAS Blood Products Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai RAAS Blood Products Co Ltd Class A. The current adx is 18.66.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shanghai RAAS Blood Products Co Ltd Class A shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai RAAS Blood Products Co Ltd Class A. The current sar is 6.70707881.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai RAAS Blood Products Co Ltd Class A. The current rsi is 61.43. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Relative Strength Index (RSI) ChartShanghai RAAS Blood Products Co Ltd Class A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai RAAS Blood Products Co Ltd Class A. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shanghai RAAS Blood Products Co Ltd Class A price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Stochastic Oscillator ChartShanghai RAAS Blood Products Co Ltd Class A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai RAAS Blood Products Co Ltd Class A. The current cci is 145.55.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Commodity Channel Index (CCI) ChartShanghai RAAS Blood Products Co Ltd Class A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai RAAS Blood Products Co Ltd Class A. The current cmo is 38.91.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Chande Momentum Oscillator (CMO) ChartShanghai RAAS Blood Products Co Ltd Class A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai RAAS Blood Products Co Ltd Class A. The current willr is -9.09090909.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Williams %R ChartShanghai RAAS Blood Products Co Ltd Class A Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai RAAS Blood Products Co Ltd Class A.

Shanghai RAAS Blood Products Co Ltd Class A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai RAAS Blood Products Co Ltd Class A. The current atr is 0.1679714.

Shanghai RAAS Blood Products Co Ltd Class A Daily Average True Range (ATR) ChartShanghai RAAS Blood Products Co Ltd Class A Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai RAAS Blood Products Co Ltd Class A. The current obv is 1,879,562,211.

Shanghai RAAS Blood Products Co Ltd Class A Daily On-Balance Volume (OBV) ChartShanghai RAAS Blood Products Co Ltd Class A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai RAAS Blood Products Co Ltd Class A. The current mfi is 55.79.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shanghai RAAS Blood Products Co Ltd Class A Daily Money Flow Index (MFI) ChartShanghai RAAS Blood Products Co Ltd Class A Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai RAAS Blood Products Co Ltd Class A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Shanghai RAAS Blood Products Co Ltd Class A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai RAAS Blood Products Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.428
Ma 20Greater thanMa 506.967
Ma 50Greater thanMa 1007.083
Ma 100Greater thanMa 2007.314
OpenGreater thanClose7.080
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shanghai RAAS Blood Products Co Ltd Class A with someone you think should read this too:
  • Are you bullish or bearish on Shanghai RAAS Blood Products Co Ltd Class A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai RAAS Blood Products Co Ltd Class A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai RAAS Blood Products Co Ltd Class A

I send you an email if I find something interesting about Shanghai RAAS Blood Products Co Ltd Class A.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai RAAS Blood Products Co Ltd Class A.

Receive notifications about Shanghai RAAS Blood Products Co Ltd Class A in your mailbox!